Clinical Trial Update: Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and tolerability of once-weekly oral aripiprazole in children and adolescents with Tourette's Disorder; results posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Tourette's Disorder | Phase 3 | Status: COMPLETED | Results posted: 2021-10-07